• Best stocks to buy now
  • Disclaimer
  • Media Coverage
Thursday, December 7, 2023
No Result
View All Result
Best Stocks
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones today
    • Pre-IPO and startups
    • Tech stocks
    • Utility stocks
  • Best Stocks toolsHOT
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Social Sentiments Checker
    • Indices
  • About us
    • About
    • Contact
Best Stocks
No Result
View All Result
Home News

Sleep Number Receives Optimistic Prognosis from Piper Sandler with Increased Target Price

Elaine Mendonça by Elaine Mendonça
July 30, 2023
in News
Reading Time: 4 mins read
A A
0
is sally's open today
0
SHARES
37
VIEWS
Share on FacebookShare on Twitter

In a recent research report issued on Friday, July 30, 2023, equities researchers at Piper Sandler made some intriguing predictions regarding Sleep Number (NASDAQ:SNBR). The researchers commendably increased the target price for the stock from $30.00 to $32.00, providing investors with an optimistic prognosis. This adjustment implies a potential upside of 17.82% from the stock’s current price.

The quarterly earnings data released by Sleep Number on Thursday, July 27th has garnered considerable attention in financial circles. The company’s performance undoubtedly caught the market by surprise, as it reported earnings per share (EPS) of $0.03 for the quarter. This impressive figure surpassed analysts’ consensus estimate of ($0.01) by an impressive $0.04.

However, it is important to note that Sleep Number faced challenges in terms of revenue during this period. While analysts had expected revenue to reach $471.39 million, the company fell slightly short with a total of $458.80 million in revenue for the quarter. Despites this slight setback, it is worth highlighting that Sleep Number demonstrated a net margin of 2.18%, indicating its ability to efficiently generate profit despite adverse circumstances.

Moreover, one cannot overlook the negative return on equity (ROE) that Sleep Number experienced during this quarter, amounting to -10.55%. While this may raise concerns among certain investors, it is crucial to consider various factors at play and evaluate them holistically before jumping to conclusions about the company’s financial standing.

When analyzing year-over-year performance, it becomes evident that Sleep Number grappled with a decline in quarterly revenue by 16.4%. This decrease may be attributed to several factors at play within both the broader market and the pillow industry itself.

It is essential to contextualize these figures within their appropriate time frames when considering investment decisions concerning Sleep Number stock. Comparing the performance during the same period in the previous year, we find that the company earned an impressive $1.54 EPS, demonstrating a significant difference from the current quarter. This stark contrast raises an expectation of growth and stabilization in future periods.

Looking ahead, sell-side analysts have provided a positive forecast for Sleep Number, foreseeing that it will post 1.5 EPS for the current year. Such predictions ignite hope among investors who eagerly await strong financial results and a potential increase in stock value.

In conclusion, Piper Sandler’s target price adjustment for Sleep Number signifies a promising future for this innovative company in the sleep industry sector. Despite some challenges faced in terms of revenue and negative ROE, Sleep Number’s ability to exceed EPS expectations showcases its resilience and adaptability amidst market fluctuations. Investors should remain cautious but optimistic as they monitor these developments closely to make informed decisions about their investments moving forward.

Disclaimer: The opinions expressed in this article are solely those of the author and do not reflect the views or advice of any particular financial institution or individual. As with any investment, it is essential to conduct thorough research and seek professional guidance before making any decisions financially.

Sleep Number Corporation

SNBR

Neutral

Updated on: 07/12/2023

Financial Health

Weak


Debt to equity ratio: Strong Sell

Price to earnings ratio: Strong Sell

Price to book ratio: Sell

DCF: Strong Buy

ROE: Neutral

Show more

Price Target

Current $14.62

Concensus $40.00


Low $40.00

Median $40.00

High $40.00

Show more

Social Sentiments

4:00 PM (UTC)

Date:07 December, 2023

0
Twitter Sentiment

0.9165
Stocktwits Sentiment

Show more

Analyst Ratings

Analyst / firm Rating
Peter Keith
Piper Sandler
Buy
Piper Sandler Buy
Show more

Mixed Signals: The Changing Landscape of Sleep Number Corporation (SNBR)



On July 30, 2023, various reports regarding sleep technology company Sleep Number Corporation (SNBR) surfaced, shedding light on the recent changes in its stock ratings and overall performance. The stock had previously gained attention from investors and analysts alike due to its promising growth prospects. However, recent developments have caused a shift in sentiment among market participants.

One notable report came from StockNews.com, which downgraded Sleep Number’s rating from “buy” to “hold.” This adjustment reflects a potentially less optimistic stance on the company’s future trajectory. The reason behind this downgrade remains undisclosed, leaving investors speculating about the underlying factors that prompted this change.

In contrast to StockNews.com’s report, Wedbush—an influential investment firm—exhibited a more positive outlook for Sleep Number. They raised their target price for the company from $27.00 to $33.00. Such an increase suggests that they believe there is still room for growth and potential value in SNBR stock.

Interestingly enough, on Friday, July 28th, shares of SNBR stock declined significantly by $11.30 before settling at $27.16—a substantial drop considering the average trading volume and historical patterns of the stock. With 1,264,981 shares traded during that session—more than double its average volume—the sudden decrease triggered alarm bells within the investor community.

As of now, Sleep Number Corporation boasts a market capitalization of approximately $602.41 million—an impressive figure that demonstrates its prominence within the sleep technology industry and investment landscape.

Taking into account certain financial metrics often used to evaluate investment opportunities like price-to-earnings ratio (P/E ratio) and beta values can provide further insights into Sleep Number’s current state as well as its potential trajectory moving forward.

With a P/E ratio of 13.09—which indicates how much investors are willing to pay for each dollar of earnings—the current valuation suggests that investors view Sleep Number as an attractive investment. Furthermore, a PEG ratio of 1.29 hints at its growth potential considering it is relatively lower than the industry average. This indicates that Sleep Number’s stock price may be undervalued relative to its underlying earnings growth.

Moreover, SNBR demonstrates a beta value of 1.95—a statistical measure indicating the stock’s sensitivity to market movements relative to a benchmark index such as the S&P 500. A beta greater than one suggests heightened volatility compared to the broader market, which can offer increased profit potential but also implies higher risk.

Looking at the historical performance of SNBR, it is worth noting that the two-hundred-day simple moving average stands at $28.46, while the fifty-day simple moving average is slightly lower at $25.68. These figures provide a glimpse into the recent trends exhibited by Sleep Number’s stock price and hint toward its potential future trajectory.

The company’s stock has experienced considerable fluctuations over the past year—with a 52-week low of $17.50 and a 52-week high of $50.61—showcasing both valleys and peaks in its journey through the market.

In conclusion, with differing reports from reputable sources and significant shifts observed in recent stock performance, vexation surrounds investors analyzing Sleep Number Corporation (SNBR). Market participants are undoubtedly deliberating on whether to hold or divest their holdings based on these mixed signals. As time progresses, it will become clearer how Sleep Number navigates these challenges and whether it can maintain its stronghold within the competitive sleep technology industry while offering desirable returns for investors.

Tags: SNBR
Elaine Mendonça

Elaine Mendonça

Over the last nine years, Elaine has managed investment portfolio using fundamental analysis and value investing, emphasizing long-term time horizons.

Discussion about this post

DISCLAIMER

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

READ MORE

Categories

Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks

Data and Tools
Stock Forecast
Dow Jones Today

Follow us on Social Media
Facebook – YouTube – Twitter

Write for us
Finance – Business

Best Stocks to Buy Now

We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.

  • Disclaimer
  • Privacy Policy
  • Best stocks to buy now
  • Contact
  • Write for us – Finance, Crypto

© 2023 Best Stocks

No Result
View All Result
  • Home
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech stocks
    • Utility Stocks
  • Best Stocks Tools
    • Stock News Sentiment
    • Stock Fundamentals Checker
    • Price Targets
    • Social Sentiments Checker
    • Indices
  • About us
    • About
    • Contact

© 2023 Best Stocks